ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $893 | +22.0% | 249,506 | +25.6% | 0.01% | +28.6% |
| Q2 2023 | $732 | -69.6% | 198,634 | -68.0% | 0.01% | -79.4% |
| Q4 2022 | $2,410 | -98.2% | 621,348 | +426.1% | 0.03% | +3300.0% |
| Q3 2021 | $133,000 | +7.3% | 118,099 | +51.5% | 0.00% | 0.0% |
| Q2 2021 | $124,000 | +7.8% | 77,941 | +18.5% | 0.00% | 0.0% |
| Q1 2021 | $115,000 | +248.5% | 65,764 | +473.0% | 0.00% | 0.0% |
| Q2 2020 | $33,000 | – | 11,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |